Abro Corporation develops antibody therapies to improve the lives of patients facing severe and life-threatening diseases. Self-described as focused on harnessing the power of the immune system to fight disease.

Abro Corporation

Abpro  | 5,174 followers on LinkedIn. Developing antibody therapies to improve the lives of patients facing severe and life-threatening diseases. | We&#39;re a biotech company dedicated to advancing antibody therapeutics for severe diseases. Focusing on immuno-oncology and ophthalmology, we leverage our proprietary DiversImmune® and MultiMab platforms to develop next-gen antibodies. Collaborating with global pharmaceutical and research partners, we&#39;re building a robust pipeline of innovative treatments.

Shaohong Liang

Director, Technology Development & Licensing at Memorial Sloan Kettering Cancer Center

Imke Ehlers Surur

Vice President of Nonclincal Research and Development at Abpro

Shaun Murphy

Scientist at Eisai Research Institute

Zuzana Dostalova

Abpro

Please find Cohen & Company Capital Markets (CCM's) quarterly update below. We are seeing dramatic improvement in DeSPAC performance for recent closed deals in addition to green shoots in the traditional IPO markets. CCM had a great start to the year with 17 announced or closed De-SPACs in Q1. Announced Deals: Webull Financial and SK Growth Opportunities Corporation (SKGR) XCF Global Capital Inc. and Focus Impact Partners (BHAC) Hunch Mobility and Direct Selling Acquisition Corp. (DSAQ) Abpro and Atlantic Coastal Acquisition (ACAB) Perception Capital Partners and @RBio Energy (PFTA) ShoulderUp and See ID (SUAC) Closed Deals: Andretti Acquisition Corp. (NYSE:WNNR) and Zapata AI (ZPTA) SIZZLE Acquisition Corp. (NASDAQ: "SZZL") and Critical Metals Corp. (CRML) Two and LatAm Logistic Properties, S.A. (LPA) Concord Acq III and GCT Semiconductor (GCTS) HCM Acquisition Co and Murano (MRNO) ESGEN Acquisition Corporation and Sunergy (ZEO) Semper Paratus and TEVOGEN BIO (TVGN) Phoenix Biotech Ltd. and CERo Therapeutics, Inc. (CERO) Newcourt Acq Corp and Psyence Group (PBM) Chenghe Acq Corp and TCO (SELX) DHC Acq and BEN AI (BNAI)

COM:ABPRO